IDEXX LABORATORIES INC /DE Defined Contribution Plan, Cost
IDEXX LABORATORIES INC /DE (IDXX) reported Defined Contribution Plan, Cost of $33.10 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-20.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DefinedContributionPlanCostRecognized · last filed 2026-02-20
- IDEXX LABORATORIES INC /DE defined contribution plan, cost for fiscal 2025 was $33.10M, a 6.77% increase from fiscal 2024.
- IDEXX LABORATORIES INC /DE defined contribution plan, cost for fiscal 2024 was $31.00M, a 2.31% increase from fiscal 2023.
- IDEXX LABORATORIES INC /DE defined contribution plan, cost for fiscal 2023 was $30.30M, a 7.07% increase from fiscal 2022.
- IDEXX LABORATORIES INC /DE defined contribution plan, cost for fiscal 2022 was $28.30M.
| Period end | Defined Contribution Plan, Cost 12 month |
|---|---|
| 2025-12-31 | $33.10M 10-K · filed 2026-02-20 |
| 2024-12-31 | $31.00M 10-K · filed 2026-02-20 |
| 2023-12-31 | $30.30M 10-K · filed 2026-02-20 |
| 2022-12-31 | $28.30M 10-K · filed 2025-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |